Patents by Inventor Peter A. Simmons

Peter A. Simmons has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260000725
    Abstract: Provided herein are low salt ophthalmic pharmaceutical composition and methods of use thereof, for example, in the treatment of dry eye syndrome.
    Type: Application
    Filed: May 13, 2025
    Publication date: January 1, 2026
    Inventors: Peter A. Simmons, Joseph G. Vehige
  • Publication number: 20250281521
    Abstract: The present invention relates to ophthalmic compositions and methods useful to treat dry eye, or to diagnose, cure, mitigate, treat, or prevent dry eye syndrome in man or other animals.
    Type: Application
    Filed: January 14, 2025
    Publication date: September 11, 2025
    Inventors: Joseph G. Vehige, Peter A. Simmons
  • Publication number: 20250186385
    Abstract: Ophthalmic compositions including compatible solute components and/or polyanionic components are useful in treating eyes, for example, to relieve dry eye syndrome, to protect the eyes against hypertonic insult and/or the adverse effects of cationic species on the ocular surfaces of eyes and/or to facilitate recovery from eye surgery.
    Type: Application
    Filed: March 3, 2025
    Publication date: June 12, 2025
    Inventors: Joseph G. Vehige, Peter A. Simmons, Joan-En Chang-Lin
  • Publication number: 20240293491
    Abstract: Provided herein are low salt ophthalmic pharmaceutical composition and methods of use thereof, for example, in the treatment of dry eye syndrome.
    Type: Application
    Filed: January 11, 2024
    Publication date: September 5, 2024
    Inventors: Peter A. Simmons, Joseph G. Vehige
  • Publication number: 20240122963
    Abstract: The present invention relates to ophthalmic compositions and methods useful to treat dry eye, or to diagnose, cure, mitigate, treat, or prevent dry eye syndrome in man or other animals.
    Type: Application
    Filed: August 28, 2023
    Publication date: April 18, 2024
    Inventors: Joseph G. Vehige, Peter A. Simmons
  • Publication number: 20230404961
    Abstract: Ophthalmic compositions including compatible solute components and/or polyanionic components are useful in treating eyes, for example, to relieve dry eye syndrome, to protect the eyes against hypertonic insult and/or the adverse effects of cationic species on the ocular surfaces of eyes and/or to facilitate recovery from eye surgery.
    Type: Application
    Filed: March 21, 2023
    Publication date: December 21, 2023
    Inventors: Joseph G. Vehige, Peter A. Simmons, Joan-En Chang-Lin
  • Publication number: 20220096523
    Abstract: The present invention relates to ophthalmic compositions and methods useful to treat dry eye, or to diagnose, cure, mitigate, treat, or prevent dry eye syndrome in man or other animals.
    Type: Application
    Filed: August 12, 2021
    Publication date: March 31, 2022
    Inventors: Joseph G. Vehige, Peter A. Simmons
  • Publication number: 20210401789
    Abstract: Ophthalmic compositions including compatible solute components and/or polyanionic components are useful in treating eyes, for example, to relieve dry eye syndrome, to protect the eyes against hypertonic insult and/or the adverse effects of cationic species on the ocular surfaces of eyes and/or to facilitate recovery from eye surgery.
    Type: Application
    Filed: May 11, 2021
    Publication date: December 30, 2021
    Inventors: Joseph G. Vehige, Peter A. Simmons, Joan-En Chang-Lin
  • Publication number: 20210245512
    Abstract: Provided herein are low salt ophthalmic pharmaceutical composition and methods of use thereof, for example, in the treatment of dry eye syndrome.
    Type: Application
    Filed: December 21, 2020
    Publication date: August 12, 2021
    Inventors: Peter A. Simmons, Joseph G. Vehige
  • Patent number: 10888598
    Abstract: Provided herein are low salt ophthalmic pharmaceutical composition and methods of use thereof, for example, in the treatment of dry eye syndrome.
    Type: Grant
    Filed: January 23, 2018
    Date of Patent: January 12, 2021
    Assignee: ALLERGAN, INC.
    Inventors: Peter A. Simmons, Joseph G. Vehige
  • Publication number: 20210000859
    Abstract: The present invention relates to ophthalmic compositions and methods useful to treat dry eye, or to diagnose, cure, mitigate, treat, or prevent dry eye syndrome in man or other animals.
    Type: Application
    Filed: February 6, 2020
    Publication date: January 7, 2021
    Inventors: Joseph G. Vehige, Peter A. Simmons
  • Publication number: 20190365692
    Abstract: Ophthalmic compositions including compatible solute components and/or polyanionic components are useful in treating eyes, for example, to relieve dry eye syndrome, to protect the eyes against hypertonic insult and/or the adverse effects of cationic species on the ocular surfaces of eyes and/or to facilitate recovery from eye surgery.
    Type: Application
    Filed: January 15, 2019
    Publication date: December 5, 2019
    Inventors: Joseph G. Vehige, Peter A. Simmons, Joan-En Chang-Lin
  • Publication number: 20190247419
    Abstract: The present invention relates to ophthalmic compositions and methods useful to treat dry eye, or to diagnose, cure, mitigate, treat, or prevent dry eye syndrome in man or other animals.
    Type: Application
    Filed: September 12, 2018
    Publication date: August 15, 2019
    Inventors: Joseph G. Vehige, Peter A. Simmons
  • Patent number: 10213405
    Abstract: Ophthalmic compositions including compatible solute components and/or polyanionic components are useful in treating eyes, for example, to relieve dry eye syndrome, to protect the eyes against hypertonic insult and/or the adverse effects of cationic species on the ocular surfaces of eyes and/or to facilitate recovery from eye surgery.
    Type: Grant
    Filed: May 3, 2017
    Date of Patent: February 26, 2019
    Assignee: ALLERGAN, INC.
    Inventors: Joseph G. Vehige, Peter A. Simmons, Joan-En Chang-Lin
  • Publication number: 20180369311
    Abstract: Provided herein are low salt ophthalmic pharmaceutical composition and methods of use thereof, for example, in the treatment of dry eye syndrome.
    Type: Application
    Filed: January 23, 2018
    Publication date: December 27, 2018
    Inventors: Peter A. Simmons, Joseph G. Vehige
  • Patent number: 10105386
    Abstract: The present invention relates to ophthalmic compositions and methods useful to treat dry eye, or to diagnose, cure, mitigate, treat, or prevent dry eye syndrome in man or other animals.
    Type: Grant
    Filed: January 21, 2015
    Date of Patent: October 23, 2018
    Assignee: ALLERGAN, INC.
    Inventors: Joseph G. Vehige, Peter A. Simmons
  • Patent number: 9907826
    Abstract: Provided herein are low salt ophthalmic pharmaceutical composition and methods of use thereof, for example, in the treatment of dry eye syndrome.
    Type: Grant
    Filed: March 23, 2016
    Date of Patent: March 6, 2018
    Assignee: ALLERGAN, INC.
    Inventors: Peter A. Simmons, Joseph G. Vehige
  • Publication number: 20180021282
    Abstract: Ophthalmic compositions including compatible solute components and/or polyanionic components are useful in treating eyes, for example, to relieve dry eye syndrome, to protect the eyes against hypertonic insult and/or the adverse effects of cationic species on the ocular surfaces of eyes and/or to facilitate recovery from eye surgery.
    Type: Application
    Filed: May 3, 2017
    Publication date: January 25, 2018
    Inventors: Joseph G. Vehige, Peter A. Simmons, Joan-En Chang-Lin
  • Patent number: 9668997
    Abstract: Ophthalmic compositions including compatible solute components and/or polyanionic components are useful in treating eyes, for example, to relieve dry eye syndrome, to protect the eyes against hypertonic insult and/or the adverse effects of cationic species on the ocular surfaces of eyes and/or to facilitate recovery from eye surgery.
    Type: Grant
    Filed: January 4, 2016
    Date of Patent: June 6, 2017
    Assignee: ALLERGAN, INC.
    Inventors: Joseph G. Vehige, Peter A. Simmons, Joan-En Chang-Lin
  • Publication number: 20160256424
    Abstract: Ophthalmic compositions including compatible solute components and/or polyanionic components are useful in treating eyes, for example, to relieve dry eye syndrome, to protect the eyes against hypertonic insult and/or the adverse effects of cationic species on the ocular surfaces of eyes and/or to facilitate recovery from eye surgery.
    Type: Application
    Filed: January 4, 2016
    Publication date: September 8, 2016
    Inventors: Joseph G. Vehige, Peter A. Simmons, Joan-En Chang-Lin